Orion Oyj's 2025 outlook projects net sales of EUR1.55-1.65 billion and operating profit of EUR350-450 million. Positive: Q1 saw growth in sales and operating profit across all divisions, with a focus on pharmaceutical development and strong clinical pipeline.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing